This is what a buyer checks before they shortlist a pharma, medical and life sciences supplier.

What does a formulator check before qualifying a new API or excipient supplier?

They check the regulatory filings before they check the price. A named pharmacopoeial grade, a DMF or ASMF reference number, the authority that issued your GMP certificate, and the markets your site is approved for decide whether qualification is even possible — long before commercial terms are discussed.

A regulatory affairs manager is building a supplier shortlist and needs to know, from your site alone, whether qualifying you is a six-month project or a non-starter.

Reviewed 4 August 2026 · Written for pharmaceutical ingredient suppliers selling to business buyers

Buyer asks

What does a formulator check before qualifying a new API or excipient supplier?

Illustrative. The question is real; it is the one this guide answers.
WHAT THEY NEED TO BELIEVEWHAT SETTLES ITWHEN THEY ASKBatch conformance to the d…Certificate of AnalysisWith every batchThat the manufacturing and…Drug Master File referenceAt shortlisting — the n…EDQM confirmation that the…Certificate of SuitabilityBy European buyers, ear…
Every claim on a supplier site has a document behind it or it does not. Buyers in pharma and ingredients know which is which.

What a buyer needs to identify the product

These are the fields a buyer scans before deciding whether you are worth contacting. Missing one of them usually ends the visit without an email.

  1. 1

    Generic name and CAS number

    The unambiguous identifier for the molecule under discussion.

  2. 2

    Pharmacopoeial grade

    IP, BP, USP, EP or JP compliance decides which markets the material can enter.

  3. 3

    Polymorphic form or particle size, where relevant

    Two materials meeting the same monograph can behave differently in a formulation.

  4. 4

    Packaging and pack sizes

    Determines storage, stability handling and shipping cost.

  5. 5

    Approved markets

    The single fastest way for a buyer to disqualify or shortlist you.

  6. 6

    Minimum order quantity

    Development quantities and commercial quantities are different conversations.

The documents buyers ask for

Not all of them belong on a public page. Naming the ones you can issue is what separates a supplier who can be audited from one who cannot.

Documents buyers ask a pharmaceutical ingredient supplier for, what each proves, and whether it belongs on the public site
DocumentWhat it provesWhere it belongs
Certificate of Analysis (CoA)Asked at: with every batchBatch conformance to the declared specificationPer shipment
Drug Master File reference (US DMF / EU ASMF)Asked at: at shortlisting — the number itself is the checkThat the manufacturing and quality detail is already on file with the authorityPublish it
Certificate of Suitability (CEP/CoS)Asked at: by european buyers, earlyEDQM confirmation that the European Pharmacopoeia monograph controls the substancePublish it
GMP certificateAsked at: vendor qualificationGood Manufacturing Practice status, and critically which authority inspected youPublish it
Manufacturing licence and site registrationAsked at: vendor qualificationThat the named site is licensed to produce the materialPublish it
Residual solvent and elemental impurity statementAsked at: technical evaluationControl against ICH Q3C and Q3D expectationsName it, share on request
Stability data summaryAsked at: before formulation work startsShelf life and storage conditions under a recognised protocolName it, share on request

Where pharma and ingredients sites lose the enquiry

Each of these is common, cheap to fix, and costs an enquiry that never arrives — so nobody ever reports it.

  • "GMP approved" with no authority named

    GMP from one national authority and GMP from a stringent regulatory authority are not the same asset, and the buyer assumes the weaker one.

  • "DMF available" with no number or filing year

    The number is the whole point — it is what the buyer looks up. Without it the claim cannot be checked and is treated as aspiration.

  • No list of approved markets

    Regulatory teams shortlist by market access first. A supplier who does not state it is filtered out before the technical review.

What the enquiry form should ask

A form that collects these can be answered properly the first time. A form that collects a name and a message cannot.

Enquiry form — pharma and ingredients

Enough to reply usefully, short enough that a buyer finishes it.

Product and pharmacopoeial grade
Decides whether a quote is possible.
Required documents
A buyer asking for a CEP and a buyer asking for a CoA are at different stages.
Quantity and packaging
Development, pilot and commercial volumes price differently.
Destination market
Registration requirements follow the market, not the molecule.
Sample or working-standard requirement
Sample requests need a different internal route from commercial enquiries.
Timeline for qualification
Tells you whether this is a live project or a market study.

Questions suppliers ask

Should we publish our DMF number publicly?

Yes. The filing itself is a matter of record with the authority and the number is what lets a buyer verify you without contacting you. Publishing it converts an unverifiable claim into a checkable fact, which is the entire job of the page.

What should we say about markets we supply but are not registered in?

Say exactly that, in those words. "Supplied to" and "registered in" are different statements and buyers know the difference. Blurring them is the kind of thing that surfaces during an audit and costs you the account rather than the enquiry.

Is a product page enough, or do we need a full regulatory section?

A product page that names grade, DMF or ASMF status and approved markets does most of the work. A separate regulatory page helps when you have several sites with different approvals, because the buyer needs to know which site makes which product.

Documents and standards named here are the ones buyers in this industry commonly ask for; requirements vary by market, customer and contract, so treat this as a starting checklist rather than a compliance list. Clearer pages can help discovery and evaluation. They do not guarantee rankings, AI citations, enquiries or revenue.

Illustrative

An enquiry from this search looks like: Product and pharmacopoeial grade · Quantity and packaging · Destination market · Timeline for qualification

Related buyer questions